Shopping Cart
- Remove All
- Your shopping cart is currently empty
1. Oxypeucedanin ((+-)-Oxypeucedanin) has novel anticancer effect, mediated via induction of G2-M cell cycle arrest and apoptosis in human prostate carcinoma DU145 cells. 2. Oxypeucedanin is a kind of open-channel blocker of the hKv1.5 channel and it prolongs the APD; therefore, it is an excellent candidate as an antiarrhythmic drug for atrial fibrillation.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $52 | In Stock | |
5 mg | $127 | In Stock | |
10 mg | $198 | In Stock | |
25 mg | $347 | In Stock | |
50 mg | $515 | In Stock | |
100 mg | $733 | In Stock | |
200 mg | $987 | In Stock |
Description | 1. Oxypeucedanin ((+-)-Oxypeucedanin) has novel anticancer effect, mediated via induction of G2-M cell cycle arrest and apoptosis in human prostate carcinoma DU145 cells. 2. Oxypeucedanin is a kind of open-channel blocker of the hKv1.5 channel and it prolongs the APD; therefore, it is an excellent candidate as an antiarrhythmic drug for atrial fibrillation. |
Alias | Oxypeucadanin, (+-)-Oxypeucedanin |
Molecular Weight | 286.28 |
Formula | C16H14O5 |
Cas No. | 737-52-0 |
Smiles | CC1(C)OC1COc1c2ccoc2cc2oc(=O)ccc12 |
Relative Density. | 1.320 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 6.88 mg/mL (24.01 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.